Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CUEDC2 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | RNASE7 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | SLC4A7 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | ATP5B | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | XPO6 | FIMM | pan-cancer | AAC | -0.44 | 0.01 |
mRNA | SYNC | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
mRNA | TMEM40 | FIMM | pan-cancer | AAC | -0.46 | 0.01 |
mRNA | PRKCQ | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | TUBA1B | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | AP3M2 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |